Perbedaan Hensel Davest Indonesia Tbk. dan Kimia Farma Tbk: Hensel Davest Indonesia Tbk. diperdagangkan di Rp50 (kapitalisasi pasar 76,23 M, volume 24 jam 3,54 jt), sedangkan Kimia Farma Tbk diperdagangkan di Rp454 (kapitalisasi pasar 2,53 T, volume 24 jam 414,5 rb). Perbedaan utamanya: Kimia Farma Tbk jauh lebih besar — sekitar 33,2× kapitalisasi pasar Hensel Davest Indonesia Tbk., dan Hensel Davest Indonesia Tbk. lebih aktif diperdagangkan (3,54 jt vs 414,5 rb). Mana yang lebih baik tergantung tujuan investasimu.
| HDIT | KAEF | |
|---|---|---|
Kapitalisasi Pasar | 76,23 M | 2,53 T |
Volume | 3,54 jt | 414,5 rb |
Lot | 35,39 rb | 4,15 rb |
Perputaran | 176,96 jt | 187 jt |
Harga Rata-rata | 50 | 451,15 |
Nilai Transaksi | 176,96 jt | 187 jt |
Harga Ekuilibrium Indikatif | 50 | 454 |
Volume Ekuilibrium Indikatif | 1 | 50 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Hensel Davest Indonesia Tbk (the Company) was established on January 7, 2013 based on Notarial Deed. 01 from Notary Soewandi Michael Barya Sugiyo SH., M.Kn.
Selengkapnya di halaman HDIT →PT Kimia Farma Tbk (the Company) was established based on the Notarial Deed No. 18 dated August 16, 1971, as amended by Notarial Deed No. 18 dated October 11, 1971 of Soelaeman Ardjasasmita, S.H., under its original name Perusahaaan Negara Farmasi dan Alat Kesehatan Bhinneka Kimia Farma (PN Farmasi Kimia Farma). PN Farmasi Kimia Farma consist of : Badan Pimpinan Umum Perusahaan-perusahaan Negara Farmasi dan Alat Kesehatan (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Radja Farma (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Nakula Farma (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Bhinneka Kimia Farma (established 1961)PN Farmasi Kimia Farma has been changed to PT Kimia Farma (Persero) Tbk based on notarial deed dated October 11, 1971. The company’s article of association has been amended from time to time, the latest of which was covered by notarial deed dated Sept 22, 2000 by Wahjono H, SH concerning Right Issue (as public company). The Company operates 210 apoteks, 6 units production and 40 branches pharmacy wholesale. The company’s share will be listed in BEJ and BES.
Selengkapnya di halaman KAEF →